2Collins AJ,Foley RN,Herzog C,et al.US Renal Data System 2012Annual Data Report[J].Am J Kidney Dis,2013,61(1 suppl1):A7;e1-476.
3Yang W,Lu J,Weng J,et al.China National Diabetes and Metabolic Disorders Study Group prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
4Arora MK,Singh UK.Molecular mechanisms in the pathogenesis of diabetic nephropathy:An update[J].Vascul Pharmacol,2013,58(4):259-271.
5Kim SH,Chunawala L,Linde R,et al.Comparison of the 1997 and2003 American Diabetes Association classification of impaired fasting glucose:Impact on prevalence of impaired fasting glucose,coronary heart disease risk factors,and coronary heart disease in a community-based medical practice[J].J Am Coll Cardiol,2006,48(2):293-297.
6Niewczas MA,Gohda T,Skupien J,et al.Circulating TNF receptors1 and 2 predict ESRD in type 2 diabetes[J].J Am Soc Nephrol,2012,23(3):507-515.
7Derosa G,Maffioli P.Efficacy and safety profile evaluation of acarbose alone andin association with other antidiabetic drugs:a systematic review[J].Clin Ther,2012,34(6):1221-1236.
8Woolf AS,Gnudil,Long DA.Roles of angiopoietins in kidney development and disease[J].J Am Soc NAephrol,2009,20(2):239-244.